Li, Mengwei
China Pharmaceutical University
3 papers on CoChatORCID 0009-0000-5859-2887
Most cited papers
- Verified
Trends in insulin resistance: insights into mechanisms and therapeutic strategy
Li, M., Chi, X., Wang, Y., Setrerrahmane, S., Xie, W., & Xu, H. (2022) · Signal Transduction and Targeted Therapy
Adipokines, Inflammation, and Metabolic DiseasesDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 939
- Verified
Significantly increased anti-tumor activity of carcinoembryonic antigen-specific chimeric antigen receptor T cells in combination with recombinant human IL-12
Chi, X., Yang, P., Zhang, E., Gu, J., Xu, H., Li, M., Gao, X., Li, X., Zhang, Y., Xu, H., et al. (2019) · Cancer Medicine
CAR-T cell therapy researchImmunotherapy and Immune Responses
Cited by 75
- Verified
Combining adoptive NK cell infusion with a dopamine-releasing peptide reduces senescent cells in aged mice
Bai, Z., Yang, P., Yu, F., Li, Z., Yao, Z., Martinez, J., Li, M., & Xu, H. (2022) · Cell Death & Disease
Telomeres, Telomerase, and SenescenceGenetics, Aging, and Longevity in Model Organisms
Cited by 43
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free